Providence Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Providence Capital Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.27M	Sell	68,413 -29	-0%	-$2.54K	0.95%	44
2026 Q1	$5.83M	Buy	68,442 +1,832	+3%	+$163K	0.95%	47
2025 Q4	$5.26M	Sell	66,610 -603	-0.9%	-$47.3K	0.89%	47
2025 Q3	$5.37M	Buy	+67,213	New	+$5.73M	0.93%	46
2022 Q1	–	Sell	-35	Closed	-$3K	–	473
2021 Q4	$3K	Hold	35	–	–	﹤0.01%	292
2021 Q3	$3K	Hold	35	–	–	﹤0.01%	268
2021 Q2	$3K	Sell	35 -37,700	-100%	-$3.08M	﹤0.01%	274
2021 Q1	$2.98M	Buy	37,735 +37,700	+107,714%	+$2.95M	1.08%	44
2020 Q4	$3K	Hold	35	–	–	﹤0.01%	273
2020 Q3	$3K	Sell	35 -45,365	-100%	-$3.46M	﹤0.01%	183
2020 Q2	$3.33M	Buy	45,400 +2,050	+5%	+$146K	1.89%	12
2020 Q1	$2.88M	Buy	43,350 +43,100	+17,240%	+$3.04M	1.73%	14
2019 Q4	$17K	Hold	250	–	–	0.01%	157
2019 Q3	$18K	Hold	250	–	–	0.01%	144
2019 Q2	$18K	Hold	250	–	–	0.01%	146
2019 Q1	$17K	Hold	250	–	–	0.01%	157
2018 Q4	$15K	Hold	250	–	–	0.01%	169
2018 Q3	$17K	Hold	250	–	–	0.01%	172
2018 Q2	$16K	Hold	250	–	–	0.01%	163
2018 Q1	$18K	Sell	250 -205	-45%	-$14.8K	0.01%	153
2017 Q4	$34K	Buy	+455	New	+$33.2K	0.03%	133

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Providence Capital Advisors's CL Position: Q2 2026 in Review

Providence Capital Advisors reduced its Colgate-Palmolive (CL) stake by 0.04% in Q2 2026, selling an estimated $2.54K and leaving 68,413 shares worth $6.27M. The position accounts for 0.95% of the portfolio, ranked #44.

Providence Capital Advisors first reported a position in CL in Q4 2017 and has held it in 21 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Providence Capital Advisors held 68,413 shares of Colgate-Palmolive worth $6.27M as of Q2 2026.
Providence Capital Advisors sold 29 Colgate-Palmolive shares in Q2 2026, an estimated $2.54K.
Colgate-Palmolive made up 0.95% of Providence Capital Advisors's portfolio in Q2 2026, its #44 holding.
Providence Capital Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 21 quarters since.
2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.